Answers are grounded in this paper and cite their sources.
A rationally designed nucleoside inhibitor of Mycobacterium tuberculosis growth (MIC(99) = 0.19 microM) that disrupts siderophore biosynthesis was identified. The activity is due to inhibition of the adenylate-forming enzyme MbtA which is involved in biosynthesis of the mycobactins.
No takes yet. Share an insight, caveat, or question.
Somu et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: